Sanja Zoričić Cvek

Prof. Dr. Sanja Zoričić Cvek

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 October 2004 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
RMRadovan Mihelic
Radovan Mihelic
MPMarko Pecina
Marko Pecina
MJMislav Jelic
Mislav Jelic
SCSanja Zoričić Cvek
Sanja Zoričić Cvek
VKVesna Kusec
Vesna Kusec
Slobodan VukicevicSlobodan Vukicevic
Slobodan Vukicevic
Background: Bone morphogenetic proteins induce new bone both in patients with bone defects and at extraskeletal sites in animals. After anterior cruciate ligament rupture, tendon graft fixation into a bone tunnel is a widely used method for anterior cruciate ligament reconstruction. Hypothesis: Bone morphogenetic protein–7 applied to the bone-tendon interface enables better integration of a free tendon graft into the surrounding bone. Study Design: Controlled laboratory study. Methods: The anterior cruciate ligament was reconstructed using a free tendon graft in the right rear knees of 30 one-year-old male sheep. Recombinant human bone morphogenetic protein–7 (25 μg) was applied randomly to the bone-tendon interface in 15 animals, and a vehicle was applied in 15 control animals. At 3 weeks, 10 animals from each group were sacrificed, and the remaining sheep were sacrificed at 6 weeks after surgery. Subsequently, histologic analysis and mechanical testing were performed. In another group of 20 sheep, the same procedure was used and mechanical testing was performed after 3 weeks. Results: More new bone was formed at the bone-tendon interface in the knees treated with bone morphogenetic protein–7 as compared histologically with similar areas in control animals, creating areas of dense trabecular network with significantly greater invasion of the tendon fibrous tissue into the bone marrow space. Mechanical testing showed greater strain resistance to force (368 N) in the knees treated with bone morphogenetic protein–7 than in control specimens (214 N). There was no difference between mechanical testing of samples from 3 and 6 weeks after surgery. Conclusion: Bone morphogenetic protein–7 promotes complete tendon graft integration into the newly formed surrounding trabecular bone in the reconstruction of the anterior cruciate ligament. Clinical Relevance: Bone morphogenetic protein–7 in tendon graft integration might be successfully used in reconstructive surgery of ligaments.

10 March 2003 in Journal of Anatomy
Verified
Journal Article
Closed access
PDF file
SCSanja Zoričić Cvek
Sanja Zoričić Cvek
IMIvana Maric
Ivana Maric
DBDragica Bobinac
Dragica Bobinac
SVSlobodan Vukicevic
Slobodan Vukicevic

10 June 2003 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
IMIvana Maric
Ivana Maric
LPLjiljana Poljak
Ljiljana Poljak
SCSanja Zoričić Cvek
Sanja Zoričić Cvek
DBDragica Bobinac
Dragica Bobinac
DBDattatreyamurty Bosukonda
Dattatreyamurty Bosukonda
Slobodan VukicevicSlobodan Vukicevic
Slobodan Vukicevic

15 May 2012 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
PDF file
IMIvana Maric
Ivana Maric
NKNatalia Kucic
Natalia Kucic
TWTamara Turk Wensveen
Tamara Turk Wensveen
ISIvana Smoljan
Ivana Smoljan
BGBlazenka Grahovac
Blazenka Grahovac
SVSlobodan Vukicevic
Slobodan Vukicevic
Beyond stimulating bone formation, bone morphogenetic proteins (BMPs) are important in development, inflammation, and malignancy of the gut. We have previously shown that BMP7 has a regenerative, anti-inflammatory, and antiproliferative effect on experimental inflammatory bowel disease (IBD) in rats. To further investigate the BMP signaling pathway we monitored the effect of BMP7 therapy on the BMP signaling components in the rat colon during different stages of experimentally induced colitis by 2,4,6-trinitrobenzene sulfonic acid (TNBS). The results showed a significantly decreased BMP7 expression in the acute phase, followed by a significantly increased BMP2 and decreased BMP6 expression during the chronic phase of colitis. BMP7 therapy influenced the expression of several BMPs with the most prominent effect on downregulation of BMP2 and upregulation of BMP4 in the chronic phase of colitis. Importantly, connective tissue growth factor and noggin expression were elevated in the acute stage and significantly decreased upon BMP7 therapy. BMP receptor I expression was unchanged, whereas BMP receptor II was decreased at day 2 and increased at days 14 and 30 of TNBS inflammation. However, an opposite pattern of expression following BMP7 therapy has been observed. BMP7 increased the expression of BR-Smad including Smad3 and Smad4. Inhibitory Smads were increased in colitis and significantly decreased following BMP7 therapy at later stages of the disease. We suggest that BMP signaling was altered during TNBS-induced colitis and was recovered with BMP7 administration, suggesting that IBD is a reversible process.

Verified
Journal Article
Open access
PDF file
Matko OguićMatko Oguić
Matko Oguić
Marija ČandrlićMarija Čandrlić
Marija Čandrlić
Matej TomasMatej Tomas
Matej Tomas
Bruno VidakovićBruno Vidaković
Bruno Vidaković
DBDorotea Blaskovic
Dorotea Blaskovic
Olga Cvijanović PelozaOlga Cvijanović Peloza
Olga Cvijanović Peloza
This prospective, randomized, controlled clinical trial reports clinical, radiographic, histologic and immunohistochemical results of autologous dentin graft (ADG) and its comparison with a mixture of bovine xenograft with autologous bone (BX+AB). After tooth extraction in the esthetic zone of maxilla, the alveolar ridge of 20 patients in the test group was augmented with ADG, while 17 patients in the control group received the combination of BX+AB. Cone beam computed tomography (CBCT) was performed before tooth extraction and after 4 months when a total of 22 bone biopsies were harvested and subjected to histological and immunohistochemical analysis. Radiological analysis showed comparable results of bone dimension loss in both groups. Quantitative histologic analysis showed comparable results with no statistically significant differences between the groups. Immunohistochemical staining with TNF-α and BMP-4 antibodies revealed immunopositivity in both groups. A statistically significant difference between the groups was found in the intensity of TNF-α in the area of newly formed bone (p = 0.0003) and around remaining biomaterial particles (p = 0.0027), and in the intensity of BMP-4 in the area around biomaterial particles (p = 0.0001). Overall, ADG showed biocompatibility and achieved successful bone regeneration in the esthetic zone of the maxilla similar to BX+AB.